CAPRICOR THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $8.98 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $4.98M.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $4.00M, a 26.58% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$10.59M, a 312.19% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$14.61K, a 100.60% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$5.19M.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$8.14M, a 5871.89% decline from fiscal 2014.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $141.04K, a 96.27% decline from fiscal 2013.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $3.78M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $8.98M 10-Q · filed 2017-08-14 | -$1.61M derived: sum of 3 quarters · filed 2017-08-14 | -$1.63M derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $4.00M 10-Q · filed 2017-05-15 | -$6.59M derived: sum of 2 quarters · filed 2017-05-15 | -$6.61M derived: sum of 3 quarters · filed 2017-05-15 | -$6.64M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-12-31 | -$10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$10.61M derived: sum of 2 quarters · filed 2017-03-16 | -$10.64M derived: sum of 3 quarters · filed 2017-08-14 | -$5.19M 10-K · filed 2017-03-16 |
| 2016-09-30 | -$14.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$46.24K derived: sum of 2 quarters · filed 2017-08-14 | $5.40M 10-Q · filed 2016-11-14 | $10.39M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-06-30 | -$31.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $5.42M 10-Q · filed 2017-08-14 | $10.41M derived: sum of 3 quarters · filed 2017-08-14 | $12.82M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $5.45M 10-Q · filed 2017-05-15 | $10.44M derived: sum of 2 quarters · filed 2017-05-15 | $12.86M derived: sum of 3 quarters · filed 2017-05-15 | $12.83M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $7.41M derived: sum of 2 quarters · filed 2017-03-16 | $7.38M derived: sum of 3 quarters · filed 2017-03-16 | -$8.14M 10-K · filed 2017-03-16 |
| 2015-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.39M derived: sum of 2 quarters · filed 2016-11-14 | -$13.13M 10-Q · filed 2016-11-14 | -$12.76M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$23.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$15.55M 10-Q · filed 2016-08-15 | -$15.17M derived: sum of 3 quarters · filed 2016-08-15 | -$15.24M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$15.52M 10-Q · filed 2016-05-13 | -$15.15M derived: sum of 2 quarters · filed 2016-05-13 | -$15.22M derived: sum of 3 quarters · filed 2016-05-13 | -$15.29M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $375.44K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $304.34K derived: sum of 2 quarters · filed 2016-03-30 | $235.36K derived: sum of 3 quarters · filed 2016-03-30 | $141.04K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$71.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$140.08K derived: sum of 2 quarters · filed 2015-11-13 | -$234.39K 10-Q · filed 2015-11-13 | $1.04M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$68.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$163.30K 10-Q · filed 2015-08-14 | $1.11M derived: sum of 3 quarters · filed 2015-08-14 | $2.21M derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | -$94.31K 10-Q · filed 2015-05-13 | $1.18M derived: sum of 2 quarters · filed 2015-05-13 | $2.28M derived: sum of 3 quarters · filed 2015-05-13 | |
| 2013-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $2.38M derived: sum of 2 quarters · filed 2015-03-16 | $3.78M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.50M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $1.40M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |